FIGURE 1.

Standardized 30‐day absolute risks and standardized 30‐day absolute risk differences for all‐cause mortality and a composite of severe COVID‐19 infection, admission to intensive care unit, or all‐cause mortality according to glycated haemoglobin (HbA1c) level among hospitalized COVID‐19 patients with diabetes. Standardized to age, sex, history of ischaemic heart disease, heart failure, atrial fibrillation, stroke, peripheral artery disease, hypertension, chronic obstructive pulmonary disease, cancer, chronic renal disease, and use of cholesterol‐lowering drugs, beta‐blockers, calcium channel blockers, renin‐angiotensin system inhibitors, aspirin, and anticoagulants. SAR, standardized absolute risk